1. Ahn SS, Irie RF, Weisenburger TH et al. Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response. Surgery 1982;92:362–367.
2. Atkins MB, O'Boyle KR, Sosman JA et al. Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma. J Clin Oncol 1994;12:1553–1560.
3. Bajetta E, Di Leo A, Zampino MG et al. Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma. J Clin Oncol 1994;12:806–811.
4. Bajorin DF, Chapman PB, Wong G et al. Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma. Cancer Res 1990;50:7490–7495.
5. Baum BJ, Cotrim AP. Gene therapy: some history, applications, problems, and prospects. Toxicol Path 2008;26(1):97–103.